Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kneebone

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Physics and Imaging in Radiation Oncology|June 30, 2025
Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapyAbdella M Ahmed, Levi Madden, Maegan Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|June 15, 2024
Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasetsPhillip Chlap, Hang Min, Jason Dowling, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2017
Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)Michael G Penniment, Paolo B De Ieso, Jennifer A Harvey, et al.
Lancet (London, England)|October 1, 2020
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataClaire L Vale, David Fisher, Andrew Kneebone, et al.
Journal of Crohn'S & Colitis|April 7, 2022
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort StudyPhilip J Smith, Lisa Critchley, Daniel Storey, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Physics and Imaging in Radiation Oncology|June 30, 2025
Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapyAbdella M Ahmed, Levi Madden, Maegan Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|June 15, 2024
Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasetsPhillip Chlap, Hang Min, Jason Dowling, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2017
Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)Michael G Penniment, Paolo B De Ieso, Jennifer A Harvey, et al.
Lancet (London, England)|October 1, 2020
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataClaire L Vale, David Fisher, Andrew Kneebone, et al.
Journal of Crohn'S & Colitis|April 7, 2022
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort StudyPhilip J Smith, Lisa Critchley, Daniel Storey, et al.
Pageof 13